Skip to main content
. 2022 Dec 26;49(3):1467–1475. doi: 10.1007/s00068-022-02204-6

Table 2.

Crude mortality rates in non-frail, pre-frail, and frail hip fracture patients

Non-frail patients
(N = 30,463)
Pre-frail patients
(N = 35,312)
Frail patients
(N = 61,530)
p value
30 days mortality, n (%) 380 (1.2) 1,500 (4.2) 7427 (12.1)  < 0.001
Cardiovascular, n (%) 156 (0.5) 557 (1.6) 3099 (5.0)  < 0.001
Respiratory, n (%) 87 (0.3) 304 (0.9) 1163 (1.9)  < 0.001
Cerebrovascular, n (%) 9 (0.0) 33 (0.1) 103 (0.2)  < 0.001
Sepsis, n (%) 8 (0.0) 33 (0.1) 137 (0.2)  < 0.001
Multiorgan failure, n (%) 109 (0.4) 522 (1.5) 2636 (4.3)  < 0.001
Unknown, n (%) 11 (0.0) 51 (0.1) 289 (0.5)  < 0.001
90 days mortality, n (%) 751 (2.5) 2858 (8.1) 12,802 (20.8)  < 0.001
Cardiovascular, n (%) 289 (0.9) 977 (2.8) 5015 (8.2)  < 0.001
Respiratory, n (%) 149 (0.5) 465 (1.3) 1708 (2.8)  < 0.001
Cerebrovascular, n (%) 20 (0.1) 88 (0.2) 276 (0.4)  < 0.001
Sepsis, n (%) 18 (0.1) 101 (0.3) 295 (0.5)  < 0.001
Multiorgan failure, n (%) 242 (0.8) 1,103 (3.1) 4814 (7.8)  < 0.001
Unknown, n (%) 33 (0.1) 124 (0.4) 694 (1.1)  < 0.001

Non-frail, pre-frail, and frail are defined as OFS 0, OFS 1, and OFS ≥ 2